For the treatment of stenotic lesions of arteriovenous fistula in the haemodialysis management of chronic renal failure
The approved product has an estimated market size of US$ 44.5 million for the twelve months ending January 2024
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ II, India
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Neurontin Tablets, 600 mg and 800 mg, of Viatris Specialty
The product will be launched in March 2024
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
Isosorbide mononitrate is used to prevent chest pain (angina) in patients with a certain heart condition (coronary artery disease)
The Pregabalin capsules has a market size of ~US$248 mn per IQVIA
The company has received five final approvals
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
